- Business Wire•4 days ago
Generex Biotechnology Corporation today announced that it has achieved the elimination of its outstanding derivative securities.
- Business Wire•10 days agoGenerex Provides Update on Deal to Acquire Controlling Equity Interest in Emmaus Life Sciences, Inc.
On January 23, 2017 Generex Biotechnology Corporation announced a letter of intent for the acquisition of a controlling equity interest in Emmaus Life Sciences, Inc. .
- Business Wire•20 days ago
Generex Biotechnology Corporation today announced that it will hold an investor conference call at 10 a.m. Eastern time on Wednesday, February 22, 2017. Dial-in instructions will be issued prior to the date of the call.
GNBT : Summary for GENEREX BIOTECH CORP - Yahoo Finance
Generex Biotechnology Corporation (GNBT)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
|Day's Range||0.01 - 0.02|
|52 Week Range||0.00 - 0.02|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||-17.40|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|